Polycystic Ovary Syndrome, PCOS Clinical Trial
Official title:
Size at Birth in Newborn Children and Obstetric Outcomes in Women With PCOS
Verified date | November 2013 |
Source | Odense University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Dataprotection Agency |
Study type | Observational |
The aim of the study is to investigate body composition in newborn children of women with PCOS and controls and to investigate adverse obstetric outcomes in pregnant women with PCOS.
Status | Completed |
Enrollment | 1248 |
Est. completion date | September 2013 |
Est. primary completion date | January 2011 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Diagnosed with PCOS and giving birth during 2003-2011 Exclusion Criteria: - Multiple pregnancy |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Endocrinology, Odense University Hospital | Odense |
Lead Sponsor | Collaborator |
---|---|
Odense University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Neonatal complications | Registration of Apgar score 5 minutes after birth and admission to neonatal intensive care unit. | Date of birth (1 day) | No |
Primary | Anthropometric measures | Abdominal circumference, birth weight, birth length, and head circumference. | Date of birth (1 day) | No |
Secondary | Adverse obstetric outcomes | Presence of gestational diabetes mellitus, pregnancy induced hypertension, or pre-eclampsia during pregnancy. Registration of gestational age at childbirth, medical induction of birth, caesarean section,instrumental delivery, anal sphincter rupture, and shoulder dystocia. | From beginning of pregnancy until the date of delivery (approximately 9 months) | No |